In this sense, the overexpression of MMP2, MMP9 and MMP3 has been detected in various types of human cancer, such oesophageal cancer [11], gastric carcinoma [12], ovarian [13] and lung cancer [14,15], and has been significantly associated with tumour progression and decreased survival. Here, MMP2 is linked to lung carcinoma.